Loss of E-cadherin in the vicinity of necrosis in colorectal carcinomas: Association with NFκB expression

International Journal of Oncology

Volumn 31, Issue 2, 2007, Pages 269-275

  Simiantonaki, Nektaria ^a   Kurzik Dumke, Ursula ^a,b   Karyofylli, Georgia ^a   Jayasinghe, Caren ^a,c   Kirkpatrick, Charles James ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Institute of Medical Microbiology and Hygiene   (Germany)

^c KLINIKUM LEVERKUSEN   (Germany)

Author keywords

Colorectal cancer; E cadherin; Necrosis; NF B

Indexed keywords

CADHERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; CARCINOMA; CELL ADHESION; CELL NUCLEUS; COLON TUMOR; COLORECTAL TUMOR; DISEASE COURSE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; NECROSIS; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; CADHERINS; CARCINOMA; CELL ADHESION; CELL LINE, TUMOR; CELL NUCLEUS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NECROSIS; NEOPLASMS; NF-KAPPA B;

EID: 35148867847     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.2.269     Document Type: Article

References (23)

1. Sen R and Baltimore D: Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttransational mechanism. Cell 47: 921-928, 1986. (Pubitemid 17005065)
2. Aggarwal BB: Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208, 2004.
3. Karin M and Greten FR: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759, 2005. (Pubitemid 41400849)
4. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436, 2006.
5. Huang S, Pettaway CA, Uehara H, Bucana CD and Fidler IJ: Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20: 4188-4197, 2001. (Pubitemid 32762193)
6. Andela VB, Schwarz EM, Puzas JE, O'Keefe RJ and Rosier RN: Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res 60: 6557-6562, 2000.
7. Simiantonaki N, Jayasinghe C and Kirkpatrick CJ: Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro. Exp Mol Pathol 73: 46-53, 2002. (Pubitemid 34775457)
8. Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153: 333-339, 1998.
9. Santini MT and Rainaldi G: Three-dimensional spheroid model in tumor biology. Pathobiology 67: 148-157, 1999.
10. Evertsson S and Sun XF: Protein expression of NF-kappaB in human colorectal adenocarcinoma. Int J Mol Med 10: 547-550, 2002.
11. Yu LL, Yu HG, Yu JP, Luo HS, Xu XM and Li JH: Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J Gastroenterol 10: 3255-3260, 2004.
12. Yu HG, Zhong X, Yang YN, et al: Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer. Int J Colorectal Dis 19: 18-22, 2004.
13. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR and Chiao PJ: The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 5: 119-127,1999. (Pubitemid 29045184)
14. Sasaki N, Morisaki T, Hashizume K, et al: Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7: 4136-4142, 2001.
15. Ross JS, Kallakury BV, Sheehan CE, et al: Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. Clin Cancer Res 10: 2466-2472, 2004.
16. Kojima M, Morisaki T, Sasaki N, Nakano K, Mibu R, Tanaka M and Katano M: Increased nuclear factor-κB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res 24: 675-681, 2004.
17. Maihofner C, Charalambous MP, Bhambra U, Lightfoot T, Geisslinger G and Gooderham NJ; CRC Group: Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis 24: 665-671, 2003.
18. Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Michel-Schmidt R and Kirkpatrick CJ: Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int J Mol Med 20: 21-29, 2007.
19. Luo JL, Maeda S, Hsu LC, Yagita H and Karin M: Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6: 297-305, 2004. (Pubitemid 39222042)
20. Andrews EJ, Wang JH, Winter DC, Laug WE and Redmond HP: Tumor cell adhesion to endothelial cells is increased by endotoxin via an upregulation of beta-1 integrin expression. J Surg Res 97: 14-19, 2001.
21. Shin SR, Sanchez-Velar N, Sherr DH and Sonenshein GE: 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB. Cancer Res 66: 2570-2575, 2006.
22. Kuphal S, Poser I, Jobin C, Hellerbrand C and Bosserhoff AK: Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene 23: 8509-8519, 2004 (Pubitemid 39540801)
23. Vakkila J and Lotze MT: Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4: 641-648, 2004. (Pubitemid 39025049)